Real-world study shows TECNIS PureSee IOL offers low levels of bothersome visual symptoms, indicating high-quality vision
Brian Schwam, MD, of Johnson & Johnson Vision, spoke with Ophthalmology 360 at the 2026 ASCRS Annual Meeting about the TECNIS PureSee intraocular lens (IOL). He presented a study that showed the IOL offered good distance intermediate visual acuity and low levels of bothersome visual symptoms.
Brian Schwam, MD:
Hello, everyone. My name is Dr. Brian Schwam at Johnson & Johnson Vision, and I’m thrilled to be with you here today from ASCRS 2026 to talk to you a bit about my paper presentation here at the meeting. I’ll be talking to you about our latest innovation in extended depth-of-focus intraocular lenses, specifically the PureSee intraocular lens.
Now, in this study, this was a post-market observation study of 293 subjects at 19 sites across Europe and Asia Pacific. Now, my presentation is 1 of 3 here at the meeting reporting the data out. I encourage our viewers to look at the other presentations as well. In my study specifically, we looked at distance and intermediate visual acuity as well as levels of bothersome dysphotopsia.
Specifically looking at the results, what we found was that the best corrected monocular distance acuity and binocular uncorrected distance visual acuity was 20/19 in both groups; 90% of subjects had binocular uncorrected visual acuity of 20/20 or better, and 97% had binocular best corrected distance acuity of 20/20 or better. In regards to intermediate vision, we found that binocular uncorrected intermediate and binocular distance-corrected intermediate vision were both 20/26. Looking at visual disturbances, what we found is greater than 90% of subjects either did not experience or, for those who did, found it not bothersome or only a little bit bothersome in regards to things like glare, halo, and starburst.
In addition, the proportion of subjects who very often experienced visual symptoms of less than 4.8% and the portion of subjects who were very bothered by visual symptoms was less than 3.1%. In summary, the results showed excellent distance intermediate visual acuity, very high levels of uncorrected and best corrected distance acuity, and low levels of bothersome visual symptoms consistent with high quality of vision.
Thank you so much.
Related Content
